TAK ALG-12.5 (Alogliptin Benzoate 12.5 mg)
Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Alogliptin benzoate 12.5 mg. It is supplied by Perrigo New York Inc..
Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for TAK ALG-12.5
Alogliptin benzoate
- Imprint:
- TAK ALG-12.5
- Strength:
- 12.5 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0103
More about alogliptin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: dipeptidyl peptidase 4 inhibitors
Consumer resources
Other brands: Nesina
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
